Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Christoph M. Hammers"'
Autor:
Sascha Ständer, Saeedeh Ghorbanalipoor, Ralf Ludwig, Christoph M. Hammers, Katja Bieber, Khalaf Kridin, Enno Schmidt, Detlef Zillikens, Artem Vorobyev
Publikováno v:
Journal of the European Academy of Dermatology and Venereology. 35:1702-1711
BACKGROUND The influence of cutaneous cellular infiltration on the phenotype of bullous pemphigoid (BP) remains to be established. OBJECTIVES To evaluate the main histopathological characteristics of patients with BP and to assess the association bet
Autor:
Inke R. König, Christian D. Sadik, Ana Luiza Lima, Enno Schmidt, A. Kleinheinz, A. Weidinger, Christoph M. Hammers, Damian Gola, A. von Georg, Franziska Hübner, Stefan W. Schneider, Alexander Katalinic, Maike M. Holtsche, N. van Beek, Regine Gläser, Detlef Zillikens
Publikováno v:
Journal of the European Academy of Dermatology and Venereology. 35:1197-1202
Background Autoimmune bullous diseases (AIBD) are rare disorders characterized by autoantibody formation against components of adhesion molecules; in pemphigoid diseases (PD), these are proteins of hemidesmosomes and basement membrane, important for
Publikováno v:
The Journal of Dermatology. 48:317-323
The association of bullous pemphigoid (BP) with solid malignancies (SM) is a matter of controversy, as previous studies produced inconclusive findings. The aim of this study was to assess the risk of SM among patients with BP and to evaluate whether
Autor:
Arnon D. Cohen, Shira Zelber-Sagi, Christoph M. Hammers, Virginia A. Jones, Khalaf Kridin, Kyle T. Amber, Payal M. Patel, Giovanni Damiani
Publikováno v:
Immunologic Research
Data regarding the association between pemphigus and rheumatoid arthritis (RA) is inconclusive and yet to be firmly established. In the current study, we aimed to evaluate the risk of developing RA during the course of pemphigus. A large-scale popula
Publikováno v:
Journal of the European Academy of Dermatology and Venereology. 34:2884-2889
Background Rituximab induces a rapid remission in most patients with pemphigus. Objective Our aim was to assess the long-term efficacy of rituximab in this disease. Method We conducted a retrospective study of 59 patients with pemphigus treated with
Autor:
Ralf Ludwig, Detlef Zillikens, Jennifer E. Hundt, Tanja Lange, Christian D. Sadik, Khalaf Kridin, Enno Schmidt, Artem Vorobyev, Christoph M. Hammers, Sascha Ständer
Publikováno v:
Journal of the European Academy of Dermatology and Venereology : JEADVReferences. 35(10)
BACKGROUND While clustering of bullous pemphigoid (BP) with neuropsychiatric diseases is well-established, the clinical and immunological profile of BP patients with this comorbidity remains to be decisively determined. OBJECTIVES To evaluate the bur
Autor:
Ralf Ludwig, Enno Schmidt, Maike M. Holtsche, Khalaf Kridin, Christoph M. Hammers, Sascha Ständer, Detlef Zillikens
Publikováno v:
Journal of Clinical Medicine
Volume 9
Issue 12
Journal of Clinical Medicine, Vol 9, Iss 3928, p 3928 (2020)
Volume 9
Issue 12
Journal of Clinical Medicine, Vol 9, Iss 3928, p 3928 (2020)
The practical implications of complement deposition in direct immunofluorescence (DIF) microscopy and its influence on the disease phenotype are poorly understood. We aimed to investigate whether the presence of complement deposition in DIF microscop
Autor:
Bernhard Mani, Enno Schmidt, Fiamma Berner, David Bomze, Anne Braun, Marie-Therese Abdou, Omar Ali, Sandra S. Ring, Antonio Cozzio, Christian D. Sadik, Stefan Diem, Mirjam Fässler, Wolfram Jochum, Shirin Emtenani, Lukas Flatz, Christoph M. Hammers, Detlef Zillikens
Publikováno v:
Journal of the American Academy of Dermatology. 82(4)
Background Anti-programmed cell death protein 1 (PD1)/programmed death-ligand 1(PD-L1) therapy frequently entails immune-related adverse events (irAEs), and biomarkers to predict irAEs are lacking. Although checkpoint inhibitors have been found to re
Autor:
Christoph M. Hammers, John R. Stanley
Publikováno v:
British Journal of Dermatology. 174:17-18